PECAM1 and neoplasm: We performed detailed histopathology analysis by comparing spatial distributions of nanoparticles (Prussian blue) with various stromal cells (CD31, SMA, F4/80, CD11c, etc.)and the target antigen-expressing (HER2) tumor cells.